Lilly, Transition Therapeutics make diabetes deal
Drug developer Transition Therapeutics Inc. said Wednesday that it will pay $1 million to license a group of potential diabetes
drugs from Eli Lilly and Co.
Health Care & Life Sciences
Articles
IU cancer center names new director
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center’s founding director, who died of cancer in February
2009.
To attack costs, Lilly accelerates R&D
With President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep
getting higher for Eli Lilly and Co.’s efforts to develop drugs faster and cheaper.
Consumer group sues Anthem over policy changes
A consumer watchdog group filed a lawsuit Monday against WellPoint’s California subsidiary on behalf of policyholders, claiming
they were pushed to take coverage with fewer benefits and higher deductibles.
State health commissioner leaving for CDC
Dr. Judy Monroe, after five years as Indiana’s public health leader, will spearhead communication between federal and state
health agencies.
Lilly to shift more employees to Covance
Greenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
Conseco shares fall after dip in fourth-quarter profits
Carmel-based insurer swings to a profit, but earnings from operations decline.
WellPoint records subpoened in California probe
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
Study: Hospital clout spurs higher Calif. health costs
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.
Officials: Weak smoking ban hurts Indianapolis’ hospitality efforts
The ongoing smoking-ban debate is getting a new spark from convention leaders trying to light a fire under
lawmakers, who have been reluctant to approve the kind of comprehensive smoking ban that
health—and now tourism—officials say is needed here.
Perils of non-family managers
A former Toyota exec blasts non-family managers for the company’s problems. Are some Indianapolis-area companies better-
or worse-off after families relinquished control?
House approves smoking ban in public places
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse
racing venues.
WellPoint CEO blames health costs for hikes
Amid attacks from Democrats over high executive salaries, Angela Braly testified in Washington, D.C., on Wednesday that big
insurance-premium increases are
the result of growing price tags for hospital care and pharmaceuticals.
California lawmakers question Anthem about rate hikes
California lawmakers grilled Anthem Blue Cross executives on Tuesday about their plan to boost individual insurance premiums
by as much as 39 percent, only to hear them blame the economy and a broken health care system.
Obama health reform plan slaps drugmakers
Drugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals
with generic competitor.
WellPoint testimony drops green flag on health reform restart
CEO Angela Braly is defending individual premium hikes one day before Obama's summit to debate his new reform proposal
with Republicans.
Medco profit rises as mail-order generics business grows
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
WellPoint to face questioning over rate hike
Executives are scheduled to testify Tuesday before a California legislative committee and on Wednesday before a U.S. House
of Representatives committee about big premium increases.
Lilly, Merck, Pfizer starting research center
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
California regulator finds Anthem Blue Cross violations
California’s insurance regulator said Monday his office has found more than 700 violations by the state’s largest for-profit
health insurer, a subsidiary of Indianapolis-based WellPoint.